California State Teachers Retirement System (CalSTRS)’s Viridian Therapeutics VRDN Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio VRDN Stock Details VRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.68M	Buy	91,402 +10,381	+13%	+$167K	﹤0.01%	1680
2026 Q1	$1.58M	Buy	81,021 +17,724	+28%	+$526K	﹤0.01%	1650
2025 Q4	$1.97M	Buy	63,297 +9,605	+18%	+$263K	﹤0.01%	1422
2025 Q3	$1.16M	Buy	53,692 +3	+0%	+$54	﹤0.01%	1714
2025 Q2	$751K	Sell	53,689 -1,021	-2%	-$13.9K	﹤0.01%	1881
2025 Q1	$737K	Hold	54,710	–	–	﹤0.01%	1866
2024 Q4	$1.05M	Buy	54,710 +8,344	+18%	+$181K	﹤0.01%	1743
2024 Q3	$1.05M	Sell	46,366 -859	-2%	-$14K	﹤0.01%	1751
2024 Q2	$614K	Buy	47,225 +4,629	+11%	+$64.1K	﹤0.01%	1998
2024 Q1	$746K	Buy	42,596 +5,202	+14%	+$101K	﹤0.01%	1954
2023 Q4	$814K	Buy	37,394 +1,398	+4%	+$22.1K	﹤0.01%	1942
2023 Q3	$552K	Sell	35,996 -2,573	-7%	-$49.1K	﹤0.01%	2141
2023 Q2	$918K	Sell	38,569 -2,163	-5%	-$55.5K	﹤0.01%	1973
2023 Q1	$1.04M	Sell	40,732 -405	-1%	-$13K	﹤0.01%	1865
2022 Q4	$1.2M	Buy	41,137 +6,085	+17%	+$140K	﹤0.01%	1788
2022 Q3	$719K	Buy	35,052 +10,620	+43%	+$191K	﹤0.01%	2120
2022 Q2	$283K	Buy	+24,432	New	+$328K	﹤0.01%	2582
2019 Q2	–	Sell	-2,617	Closed	-$110K	–	3080
2019 Q1	$110K	Hold	2,617	–	–	﹤0.01%	2895
2018 Q4	$119K	Hold	2,617	–	–	﹤0.01%	2903
2018 Q3	$219K	Hold	2,617	–	–	﹤0.01%	2858
2018 Q2	$252K	Buy	2,617 +886	+51%	+$93.7K	﹤0.01%	2809
2018 Q1	$182K	Buy	1,731 +347	+25%	+$37.7K	﹤0.01%	2823
2017 Q4	$216K	Buy	1,384 +78	+6%	+$9.94K	﹤0.01%	2801
2017 Q3	$179K	Sell	1,306 -187	-13%	-$31.5K	﹤0.01%	2903
2017 Q2	$290K	Buy	+1,493	New	+$252K	﹤0.01%	2772

Other funds holding VRDN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s VRDN Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) increased its Viridian Therapeutics (VRDN) stake by 13% in Q2 2026, buying an estimated $167K and bringing the position to 91,402 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1680.

California State Teachers Retirement System (CalSTRS) first reported a position in VRDN in Q2 2017 and has held it in 25 quarters since. The position peaked at $1.97M in Q4 2025. 214 funds tracked by Wall St. Rank hold VRDN as of Q2 2026.

California State Teachers Retirement System (CalSTRS) held 91,402 shares of Viridian Therapeutics worth $1.68M as of Q2 2026.
California State Teachers Retirement System (CalSTRS) bought 10,381 Viridian Therapeutics shares in Q2 2026, an estimated $167K.
Viridian Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #1680 holding.
California State Teachers Retirement System (CalSTRS) first reported a position in Viridian Therapeutics in Q2 2017 and has held it in 25 quarters since.
California State Teachers Retirement System (CalSTRS)'s Viridian Therapeutics position peaked at $1.97M in Q4 2025.
214 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.